WASHINGTON, Dec. 12, 2018 /PRNewswire/ -- 2018 has seen extensive health-focused merger and partnership activity, with nearly 840 deals announced as of Q3. Players new to the industry are driving innovation in the traditionally cautious health and life sciences sectors, with unanticipated and innovative alliances poised to revolutionize health care. McDermott Will & Emery is at the forefront of this activity, helping progressive leaders redefine and navigate the health care landscape through Collaborative Transformations – game-changing partnerships that drive bold and creative business solutions.
Attorneys from McDermott Will & Emery’s Health Industry Advisory practice discuss important Collaborative Transformations of 2018, what’s coming in 2019, and how this helps organizations positively disrupt the health and life sciences industries.
McDermott Will & Emery works with health and life sciences organizations to drive innovation through Collaborative Transformations: unusual partnerships that are helping solve some of these industries’ toughest challenges.
McDermott Will & Emery helps progressive leaders redefine and navigate the health care and life sciences landscape through Collaborative Transformations - game-changing partnerships that drive bold and creative business solutions.
Health care organizations are increasingly seeing the value of partnering - sometimes in unexpected ways. Learn how to make these collaborative transformations both seamless and successful.
Through collaborative transformations, health and life sciences organizations are embracing new ways of engaging and working with partners both from inside and outside the health sector. This is ultimately helping to improve quality of care, increase operational efficiencies and reduce costs, while dramatically redefining what consumers have come to expect from their health care experience.
"Visionaries are exploring new approaches to develop and bring pioneering health care solutions to market," said Stephen W. Bernstein, partner and International Head of McDermott's Health Industry Advisory Group. "Whether organizations are looking to collaborate across industries or across the world, our team has the experience and industry knowledge to help them align different perspectives, cultures, risk tolerance and business processes as these new relationships begin. We're passionate about the results our clients are achieving, and are excited to continue working closely with them as they drive to improve health care through these collaborative transformations."
Whether fostering breakthrough mergers, acquisitions and affiliations, clearing the way for innovative products and services, or navigating strategic investments and alliances across industries and borders, McDermott is committed to helping clients achieve the transformations they seek. Examples of how the Firm has assisted clients in these undertakings:
The Carle Foundation: we advised The Carle Foundation on its unique partnership with the University of Illinois to develop a highly focused college of medicine, the Carle Illinois College of Medicine. The new medical school will focus on the intersection of engineering and medicine, bringing together health care and academic systems to develop tomorrow's leaders.
Air Medical Group Holdings: our team represented Air Medical Group Holdings (AMGH), a KKR portfolio company, in its $2.44 billion acquisition of American Medical Response (AMR), a medical transportation company, from Envision Healthcare Corporation. This collaboration will help better serve their nearly 5 million global patients who are transported annually.
Innate Pharma: Innate Pharma called on McDermott to represent them in their new multi-term agreement with AstraZeneca and its global biologics research and development arm MedImmune. The agreement, which builds on an existing collaboration, aims to accelerate each company's oncology portfolio and bring new medicines to patients more quickly.
CVS + Aetna: McDermott is one of the firms that has advised CVS Health in connection with its $69 billion purchase of Aetna. The transaction, one of this year's largest M&A deals, is expected to transform the US health care sector.
McDermott Will & Emery is the nation's leading health care law firm. The Health Industry Advisory group is the only health practice to receive top national rankings from US News – Best Lawyers "Best Law Firms," Chambers USA, The Legal 500 US, and Law360. The practice was also recognized by Chambers as "Health Team of the Year" in 2010, 2013 and 2017. Since 2017, McDermott has also taken the top spot in PitchBook's League Tables as the most active firm for health care private equity.
At the heart of our practice is a skilled and dedicated team of lawyers with cross-functional and cross-border capabilities. To learn more about our team and our approach to Collaborative Transformation, visit MWE.com/CollaborativeTransformation. Also join us for our Hospital/Health System Collaborative Transformation Forum at the at 2019 J.P. Morgan Healthcare Conference, January 7–9, 2019 in San Francisco. Event and registration details are available here.
About McDermott Will & Emery McDermott Will & Emery is a premier international law firm with a diversified business practice. Numbering more than 1,000 lawyers, we have offices in Boston, Brussels, Chicago, Dallas, Düsseldorf, Frankfurt, Houston, London, Los Angeles, Miami, Milan, Munich, New York, Orange County, Paris, San Francisco, Seoul, Silicon Valley and Washington, DC. Further extending our reach into Asia, we have a strategic alliance with MWE China Law Offices in Shanghai.
Share this article